Array BioPharma

Patent cliffs & loss of exclusivity

A biopharmaceutical company developing and commercializing targeted small molecule drugs for the treatment of cancer and other conditions

Company

AngelList URLhttps://angel.co/array-biopharma
CAGE Code7GFS2
Legal NameArray BioPharma, Inc.
Company Operating StatusAcquired
Crunchbase URLhttps://www.crunchbase.com/organization/array-biopharma
Facebook URLhttps://www.facebook.com/Pfizer
Instagram URLhttps://www.instagram.com/pfizerinc/
LinkedIn URLhttp://www.linkedin.com/company/array-biopharma

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. BRAFTOVIENCORAFENIBSmall mol.Nov 2032
  2. BRAFTOVIENCORAFENIBSmall mol.Aug 2033
  3. MEKTOVIBINIMETINIBSmall mol.Oct 2033

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.